TRESCON
Back to All Ratios
|
TRESCON Last 5 Year Core EBITDA Growth History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Core EBITDA Growth(%) | 104.70 | -60.32 | -11.01 | 475.49 | -48.48 |
What is the latest Core EBITDA Growth ratio of TRESCON ?
Year | Core EBITDA Growth |
---|---|
Mar2023 | 104.70 |
Mar2022 | -60.32 |
Mar2021 | -11.01 |
Mar2020 | 475.49 |
Mar2019 | -48.48 |
How is Core EBITDA Growth of TRESCON Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2023 | 104.7 | Positive | |
Mar2022 | -60.32 | Negative | |
Mar2021 | -11.01 | Negative | |
Mar2020 | 475.49 | Positive | |
Mar2019 | -48.48 | - |
Other Financial Ratios of TRESCON
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of TRESCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRESCON | ₹129.0 Cr | 5.2% | 11.1% | 34.7% | Stock Analytics | |
INDRAYANI BIOTECH | ₹240.9 Cr | 0.9% | -11.4% | -28.9% | Stock Analytics |
TRESCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRESCON | 5.2% |
11.1% |
34.7% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses